Oscar Health Inc. [OSCR] is -23.69% lower this YTD. Is it still time to buy?

Oscar Health Inc. [NYSE: OSCR] stock went on an upward path that rose over 1.53% on Thursday, amounting to a one-week price increase of more than 3.28%. The company report on August 15, 2022 that Cigna + Oscar Expands Footprint to Bring Small Businesses in Philadelphia Access to Cost-Effective Health Plans.

Top 5 Tech Stocks Every Investor Should Buy Right Now

While finding excellent stocks with the potential for gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Tech Stocks Every Investor Should Buy Right Now", we have identified five tech stocks we believe could appreciate.

Sign up here to get your free report now.


Cigna + Oscar will offer small businesses access to affordable, member-first health insurance products in Bucks, Chester, Delaware, Montgomery, and Philadelphia counties.1.

Includes low cost prescription coverage, behavioral health support, and Cigna’s networks of quality physicians, specialists, and hospitals.

Over the last 12 months, OSCR stock dropped by -66.40%. The one-year Oscar Health Inc. stock forecast points to a potential upside of 21.6. The average equity rating for OSCR stock is currently 3.00, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $1.25 billion, with 211.31 million shares outstanding and 150.86 million shares in the current float. Compared to the average trading volume of 1.85M shares, OSCR stock reached a trading volume of 2705014 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Oscar Health Inc. [OSCR]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OSCR shares is $7.64 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OSCR stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

BofA Securities have made an estimate for Oscar Health Inc. shares, keeping their opinion on the stock as Underperform, with their previous recommendation back on June 15, 2022. While these analysts kept the previous recommendation, BofA Securities raised their target price from $12 to $6. The new note on the price target was released on May 26, 2022, representing the official price target for Oscar Health Inc. stock. Previously, the target price had yet another raise from $6.50 to $9, while Goldman kept a Sell rating on OSCR stock. On January 06, 2022, analysts decreased their price target for OSCR shares from 25 to 9.

The Average True Range (ATR) for Oscar Health Inc. is set at 0.34, with the Price to Sales ratio for OSCR stock in the period of the last 12 months amounting to 0.43. The Price to Book ratio for the last quarter was 1.02, with the Price to Cash per share for the same quarter was set at 11.29. Price to Free Cash Flow for OSCR in the course of the last twelve months was 6.36.

OSCR Stock Performance Analysis:

Oscar Health Inc. [OSCR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.28. With this latest performance, OSCR shares dropped by -23.69% in over the last four-week period, additionally sinking by -26.50% over the last 6 months – not to mention a drop of -66.40% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OSCR stock in for the last two-week period is set at 44.96, with the RSI for the last a single of trading hit 42.71, and the three-weeks RSI is set at 47.28 for Oscar Health Inc. [OSCR]. The present Moving Average for the last 50 days of trading for this stock 6.04, while it was recorded at 6.07 for the last single week of trading, and 6.87 for the last 200 days.

Insight into Oscar Health Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Oscar Health Inc. [OSCR] shares currently have an operating margin of -29.61. Oscar Health Inc.’s Net Margin is presently recorded at -31.14.

Return on Equity for this stock declined to -62.37, with Return on Assets sitting at -24.95.


The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OSCR. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Oscar Health Inc. go to 34.00%.

Oscar Health Inc. [OSCR] Insider Position Details

There are presently around $947 million, or 92.00% of OSCR stock, in the hands of institutional investors. The top three institutional holders of OSCR stocks are: THRIVE CAPITAL MANAGEMENT, LLC with ownership of 37,614,286, which is approximately 0% of the company’s market cap and around 0.50% of the total institutional ownership; BAILLIE GIFFORD & CO, holding 20,785,630 shares of the stock with an approximate value of $124.51 million in OSCR stocks shares; and GENERAL CATALYST GROUP MANAGEMENT, LLC, currently with $86.64 million in OSCR stock with ownership of nearly 0% of the company’s market capitalization.

Positions in Oscar Health Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 83 institutional holders increased their position in Oscar Health Inc. [NYSE:OSCR] by around 19,657,496 shares. Additionally, 50 investors decreased positions by around 22,102,293 shares, while 28 investors held positions by with 116,282,382 shares. The mentioned changes placed institutional holdings at 158,042,171 shares, according to the latest SEC report filing. OSCR stock had 40 new institutional investments in for a total of 3,952,335 shares, while 32 institutional investors sold positions of 16,221,626 shares during the same period.


Please enter your comment!
Please enter your name here